Michael I. Anstead, MD, FCCP

Medical Director, Center for Lung Transplant
Director, Adult Cystic Fibrosis Center

Clinical interests

  • Asthma
  • Atypical Mycobacterial Infections
  • Bronchiectasis
  • Cystic Fibrosis
  • Pulmonary Medicine

Michael I. Anstead, MD, FCCP

Medical Director, Center for Lung Transplant
Director, Adult Cystic Fibrosis Center

Biography

My name is Michael Anstead; I received my medical degree from the University of Kentucky, College of Medicine, Lexington. I completed a fellowship at the University of Kentucky, Lexington.

I am board certified by the American Board of Sleep Medicine and the American Board of Internal Medicine in Pulmonary Disease and Critical Care Medicine.

Faculty rank

Professor of Pediatrics

Education

Degree
University of Kentucky, College of Medicine, Lexington

Residency
University of Kentucky, Lexington

Fellowship
University of Kentucky, Lexington

Certifications or Special training
American Board of Internal Medicine, Critical Care Medicine
American Board of Internal Medicine, Pulmonary Disease
American Board of Sleep Medicine

Pediatric Sleep

Good Samaritan Pediatric Sleep Center

UK Good Samaritan Hospital
310 S. Limestone
Lexington KY 40508-3008

Call 859-323-6211
Call 800-333-8874

Monday - Friday, 8 a.m. - 4:30 p.m.

Amenities
ATM, Chaplain, Chapel, Communication assistance, Dining, Fax and copy machines, Gift shop, Guest accommodations, Internet/Wi-Fi, Lost & found, Notary, Parking, Patient & family services, Pharmacy services, Public transportation, Showers, Telephones

Directions to UK Good Samaritan Hospital Parking »



Pediatric Pulmonology

Kentucky Clinic
Second Floor, Wing D, Suite K201
740 S. Limestone
Lexington KY 40536-0284

HBCicon120x123
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »

Call 859-323-6211
Fax 859-257-1888

Amenities
Dining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs

Kentucky Clinic Map (PDF, 616 KB) »
Directions to Kentucky Clinic Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M. Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis. J Cyst Fibros. 2014 Sep;13(5):542-9.
    View in: PubMed
  2. Anstead M, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Goss CH, Rose L, Burns JL, Marshall B, Ratjen F. Pulmonary exacerbations in CF patients with early lung disease. J Cyst Fibros. 2014 Jan;13(1):74-9.
    View in: PubMed
  3. Anstead M, Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. J Cyst Fibros. 2013 Mar;12(2):147-53.
    View in: PubMed
  4. Ratjen F, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Thompson V, Emmett P, Marshall B, Accurso F, Sagel S, Anstead M. Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest. 2012 Nov; 142(5):1259-66. PMID: 22595153.
    View in: PubMed
  5. Wells J, Rosenberg M, Hoffman G, Anstead M, Farrell PM. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics. 2012 Feb; 129(2):e339-47. PMID: 22291119.
    View in: PubMed
  6. Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol. 2012 Jul; 47(7):641-8. PMID: 22684984.
    View in: PubMed
  7. Green N, Burns JL, Mayer-Hamblett N, Kloster M, Lands LC, Anstead M, Ratjen F, Saiman L. Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis. J Clin Microbiol. 2011 Jul; 49(7):2772-3. PMID: 21543567.
    View in: PubMed
  8. Ballard HO, Shook LA, Bernard P, Anstead MI, Kuhn R, Whitehead V, Grider D, Crawford TN, Hayes D. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. Pediatr Pulmonol. 2011 Feb; 46(2):111-8. PMID: 20963840.
    View in: PubMed
  9. Murphy BS, Bush HM, Sundareshan V, Davis C, Hagadone J, Cory TJ, Hoy H, Hayes D, Anstead MI, Feola DJ. Characterization of macrophage activation states in patients with cystic fibrosis. J Cyst Fibros. 2010 Sep; 9(5):314-22. PMID: 20570573.
    View in: PubMed
  10. Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2010 May 5; 303(17):1707-15. PMID: 20442386.
    View in: PubMed
  11. Hayes D, Anstead MI, Warner RT, Kuhn RJ, Ballard HO. Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis. Am J Health Syst Pharm. 2010 May 1; 67(9):737-40. PMID: 20410549.
    View in: PubMed
  12. Hayes D, Murphy BS, Kuhn RJ, Anstead MI, Feola DJ. Mucoid Inquilinus limosus in a young adult with cystic fibrosis. Pediatr Pulmonol. 2009 Jun; 44(6):619-21. PMID: 19434691.
    View in: PubMed
  13. Hayes D, Anstead MI, Ho J, Phillips BA. Insomnia and chronic heart failure. Heart Fail Rev. 2009 Sep; 14(3):171-82. PMID: 18758945.
    View in: PubMed
  14. Hayes D, Kanga JF, Anstead MI, Kuhn RJ. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Pediatr Pulmonol. 2008 May; 43(5):511-3. PMID: 18383117.
    View in: PubMed
  15. Murphy BS, Sundareshan V, Cory TJ, Hayes D, Anstead MI, Feola DJ. Azithromycin alters macrophage phenotype. J Antimicrob Chemother. 2008 Mar; 61(3):554-60. PMID: 18230686.
    View in: PubMed
  16. Ballard HO, Anstead MI, Shook LA. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Respir Res. 2007; 8:41. PMID: 17550598.
    View in: PubMed
  17. Hayes D, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect. 2007 Apr; 54(4):e211-3. PMID: 17207858.
    View in: PubMed
  18. Robinson CA, Kuhn RJ, Craigmyle J, Anstead MI, Kanga JE. Susceptibility of pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis. Pharmacotherapy. 2001 Nov; 21(11):1320-4. PMID: 11714203.
    View in: PubMed
  19. Anstead MI, Hunt TA, McConnell JW, Burki NK. Effects of therapeutic doses of albuterol on beta2-adrenergic receptor density and metabolic changes. J Asthma. 2001 Feb; 38(1):59-64. PMID: 11256555.
    View in: PubMed
  20. Anstead M. Pediatric sleep disorders: new developments and evolving understanding. Curr Opin Pulm Med. 2000 Nov; 6(6):501-6. PMID: 11100960.
    View in: PubMed
  21. Anstead M, Phillips B. The spectrum of sleep-disordered breathing. Respir Care Clin N Am. 1999 Sep; 5(3):363-77, viii. PMID: 10419581.
    View in: PubMed
  22. Anstead M, Phillips B, Buch K. Tolerance and intolerance to continuous positive airway pressure. Curr Opin Pulm Med. 1998 Nov; 4(6):351-4. PMID: 10813215.
    View in: PubMed
  23. Phillips BA, Anstead MI, Gottlieb DJ. Monitoring sleep and breathing: methodology. Part I: Monitoring breathing. Clin Chest Med. 1998 Mar; 19(1):203-12. PMID: 9554228.
    View in: PubMed
  24. Anstead MI, Hunt TA, Carlson SL, Burki NK. Variability of peripheral blood lymphocyte beta-2-adrenergic receptor density in humans. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):990-2. PMID: 9517622.
    View in: PubMed
  25. Subramanian V, Anstead M, Cottrill CM, Kanga J, Gurley J. Tetralogy of Fallot with absent pulmonary valve and bronchial compression: treatment with endobronchial stents. Pediatr Cardiol. 1997 May-Jun; 18(3):237-9. PMID: 9142722.
    View in: PubMed
  26. Tush GM, Anstead MI. Pralidoxime continuous infusion in the treatment of organophosphate poisoning. Ann Pharmacother. 1997 Apr; 31(4):441-4. PMID: 9101007.
    View in: PubMed